269 related articles for article (PubMed ID: 4640947)
1. The role of iron in the pathogenesis of porphyria cutanea tarda. An in vitro model.
Kushner JP; Lee GR; Nacht S
J Clin Invest; 1972 Dec; 51(12):3044-51. PubMed ID: 4640947
[TBL] [Abstract][Full Text] [Related]
2. The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase.
Kushner JP; Steinmuller DP; Lee GR
J Clin Invest; 1975 Sep; 56(3):661-7. PubMed ID: 1159079
[TBL] [Abstract][Full Text] [Related]
3. Familial porphyria cutanea tarda: the pattern of porphyrins formed from porphobilinogen by hemolysates.
Alleman MA; Wilson JH; van den Berg JW; Edixhoven-Bosdijk A; van Gastel-Quist LM
Clin Chem; 1982 May; 28(5):1144-7. PubMed ID: 7074894
[TBL] [Abstract][Full Text] [Related]
4. The role of iron in experimental porphyria and porphyria cutanea tarda.
Siersema PD; van Helvoirt RP; Cleton-Soeteman MI; de Bruijn WC; Wilson JH; van Eijk HG
Biol Trace Elem Res; 1992 Oct; 35(1):65-72. PubMed ID: 1384628
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietic porphyria of the fox squirrel Sciurus niger.
Levin EY; Flyger V
J Clin Invest; 1973 Jan; 52(1):96-105. PubMed ID: 4682390
[TBL] [Abstract][Full Text] [Related]
6. Activation of uroporphyrinogen decarboxylase by ferrous iron in porphyria cutanea tarda.
Blekkenhorst GH; Eales L; Pimstone NR
S Afr Med J; 1979 Nov; 56(22):918-20. PubMed ID: 515872
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of 5-aminolevulinic acid metabolism by uroporphyrinogen I in rat liver homogenate.
Shivji A; Bernstein M
Clin Biochem; 1985 Apr; 18(2):88-91. PubMed ID: 4017229
[TBL] [Abstract][Full Text] [Related]
8. Porphyrin biosynthesis from ALA and PBG by human erythrocytes in porphyrin disorders. Kinetic studies of the isomer series I and III.
Schermuly E; Doss M
Ann Clin Res; 1976; 8 Suppl 17():92-102. PubMed ID: 1008503
[TBL] [Abstract][Full Text] [Related]
9. Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda.
Elder GH; Lee GB; Tovey JA
N Engl J Med; 1978 Aug; 299(6):274-8. PubMed ID: 661926
[TBL] [Abstract][Full Text] [Related]
10. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection.
Moran MJ; Fontanellas A; Brudieux E; Hombrados I; de Ledinghen V; Couzigou P; de Verneuil H; De Salamanca RE
Hepatology; 1998 Feb; 27(2):584-9. PubMed ID: 9462661
[TBL] [Abstract][Full Text] [Related]
11. "Glucose effect" and rate limiting function of uroporphyrinogen synthase on porphyrin metabolism in hepatocyte culture: relationship with human acute hepatic porphyrias.
Doss M; Sixel-Dietrich F; Verspohl F
J Clin Chem Clin Biochem; 1985 Sep; 23(9):505-13. PubMed ID: 4067519
[TBL] [Abstract][Full Text] [Related]
12. Dual mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron: its potential role in the genesis of porphyria cutanea tarda.
Mukerji SK; Pimstone NR; Burns M
Gastroenterology; 1984 Dec; 87(6):1248-54. PubMed ID: 6489695
[TBL] [Abstract][Full Text] [Related]
13. Iron and hepatic uroporphyrin synthesis. Relation in porphyria cutanea tarda.
Felsher BF; Jones ML; Redeker AG
JAMA; 1973 Nov; 226(6):663-5. PubMed ID: 4800611
[No Abstract] [Full Text] [Related]
14. In vitro studies of the mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron under anaerobic conditions.
Mukerji SK; Pimstone NR
Arch Biochem Biophys; 1986 Feb; 244(2):619-29. PubMed ID: 3947082
[TBL] [Abstract][Full Text] [Related]
15. The activities of uroporphyrinogen synthetase and cosynthetase in congenital erythropoietic porphyria (CEP).
Miyagi K; Petryka ZJ; Bossenmaier I; Cardinal R; Watson CJ
Am J Hematol; 1976; 1(1):3-21. PubMed ID: 984034
[TBL] [Abstract][Full Text] [Related]
16. [Porphyria cutanea tarda in a chronic hemodialysis patient].
Kano T; Yamane Y; Suzuki M; Yaoita H
Nihon Hifuka Gakkai Zasshi; 1989 Jun; 99(7):819-26. PubMed ID: 2685417
[TBL] [Abstract][Full Text] [Related]
17. A potential biochemical explanation for the genesis of porphyria cutanea tarda. Studies on the inherent biochemical defect in highly purified human erythrocyte uroporphyrinogen decarboxylase and its amplification by iron.
Mukerji SK; Pimstone NR; Tan KT
FEBS Lett; 1985 Sep; 189(2):217-20. PubMed ID: 4043380
[TBL] [Abstract][Full Text] [Related]
18. Travelling wave ion mobility mass spectrometry of 5-aminolaevulinic acid, porphobilinogen and porphyrins.
Benton CM; Lim CK; Moniz C; Jones DJ
Rapid Commun Mass Spectrom; 2012 Feb; 26(4):480-6. PubMed ID: 22279024
[TBL] [Abstract][Full Text] [Related]
19. Studies in porphyria. VI. Biosynthesis of porphyrins in mammalian skin and in the skin of porphyric patients.
Bickers DR; Keogh L; Rifkind AB; Harber LC; Kappas A
J Invest Dermatol; 1977 Jan; 68(1):5-9. PubMed ID: 830770
[TBL] [Abstract][Full Text] [Related]
20. Iron and uroporphyrin in hepatocytes of inbred mice in experimental porphyria: a biochemical and morphological study.
Siersema PD; van Helvoirt RP; Ketelaars DA; Cleton MI; de Bruijn WC; Wilson JH; van Eijk HG
Hepatology; 1991 Dec; 14(6):1179-88. PubMed ID: 1959868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
